83 related articles for article (PubMed ID: 741967)
41. [Vasculo-Behçet's disease with superior sagittal sinus thrombosis--case report (author's transl)].
Ueda T; Gondo M; Kitano I; Kinoshita K; Kikuchi I
No To Shinkei; 1982 Apr; 34(4):349-54. PubMed ID: 7093071
[TBL] [Abstract][Full Text] [Related]
42. [Portal cavernoma and inferior caval thrombosis disclosing Behçet's disease].
Tlili-Graies K; Jemni L; Allegue M; Kraiem C; Chatti N; Ben Romdhane MH; Ghariani T; Jeddi M
Ann Med Interne (Paris); 1988; 139(6):444-6. PubMed ID: 3223682
[No Abstract] [Full Text] [Related]
43. Serum neopterin levels in Behçet's syndrome.
Keser G; Oksel F; Aksu K; Kabasakal Y; Gümüşdiş G; Doganavş argil E; Sin A
Clin Rheumatol; 2000; 19(4):328-9. PubMed ID: 10941821
[No Abstract] [Full Text] [Related]
44. [Studies on fibrinolytic activity in Behçet's disease. I. Measurement by fibrin plat method].
Saito K
Nippon Ganka Gakkai Zasshi; 1973 Jul; 77(7):685-92. PubMed ID: 4269949
[No Abstract] [Full Text] [Related]
45. Behçet's syndrome and oral fibrinolytic therapy.
Cunliffe WJ; Roberts BE; Dodman B
Br Med J; 1973 May; 2(5864):486-7. PubMed ID: 4712497
[No Abstract] [Full Text] [Related]
46. The prethrombotic/hypercoagulable state of Behçet's disease: comment on the article by Golden et al.
Haznedaroğlu IC; Büyükaşik Y; Ozdemir O; Ozcebe OI; Dündar SV; Kirazli S
Arthritis Rheum; 1997 Oct; 40(10):1915-6. PubMed ID: 9336441
[No Abstract] [Full Text] [Related]
47. [Behcet's disease with circulating anticoagulant].
Pedinielli FJ; Taillan B; Blanc AP; Medvedowsky JL; Juan-Vague I; Jauffret P
Presse Med; 1984 Apr; 13(18):1157. PubMed ID: 6232561
[No Abstract] [Full Text] [Related]
48. Impaired haemostatic kinetics and endothelial function in Behçet's disease.
Haznedaroglu IC; Ozcebe OI; Ozdemir O; Celik I; Dündar SV; Kirazli S
J Intern Med; 1996 Oct; 240(4):181-7. PubMed ID: 8918508
[TBL] [Abstract][Full Text] [Related]
49. Butyrate-Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome.
Emmi G; Bettiol A; Niccolai E; Ramazzotti M; Amedei A; Pagliai G; Taddei N; Sofi F; Fiorillo C; Prisco D; Becatti M
Circ Res; 2021 Jan; 128(2):278-280. PubMed ID: 33198585
[No Abstract] [Full Text] [Related]
50. Eicosanoids in the prethrombotic state of Behçet's disease.
Haznedaroğlu IC; Dündar S; Kirazh S
Thromb Res; 1995 Dec; 80(5):445-6. PubMed ID: 8588207
[No Abstract] [Full Text] [Related]
51. Thrombotic tendency in patients with Behçet's disease.
Balta I; Balta S; Demirkol S; Kucuk U
Acta Med Iran; 2015 Apr; 53(4):256. PubMed ID: 25871026
[No Abstract] [Full Text] [Related]
52. [Microtubules in polymorphonuclear leukocytes from patients with Behçet's disease].
Saga T; Matsuda H
Nippon Ganka Gakkai Zasshi; 1985 Feb; 89(2):349-53. PubMed ID: 4003214
[No Abstract] [Full Text] [Related]
53. [Hemagglutination in Behcet's disease and other diseases. Its significance in diagnosis].
UJIHARA S; KOGURE M
Rinsho Ganka; 1962 Mar; 16():305-8. PubMed ID: 13923624
[No Abstract] [Full Text] [Related]
54. [Sialic acid value in Behcet's disease].
Hatano M; Obara Y; Miyashita H; Sase Y
Nihon Ganka Kiyo; 1971 Nov; 22(11):952-3. PubMed ID: 5169202
[No Abstract] [Full Text] [Related]
55. Arachidonic acid metabolites in Behçet's disease.
Bozkurt M; Gürer MA; Gülekon A; Keskin N; Ercan S
Int J Dermatol; 1989 Mar; 28(2):141-2. PubMed ID: 2737813
[No Abstract] [Full Text] [Related]
56. Polymorphonuclear function in Behçet's syndrome.
Friman C; Davis P
Ann Rheum Dis; 1983 Aug; 42(4):477-8. PubMed ID: 6309103
[No Abstract] [Full Text] [Related]
57. Importance of serum amyloid-A in Behçet's disease.
Agilli M; Aydin FN; Kurt YG; Cayci T
Clin Rheumatol; 2016 Feb; 35(2):551-2. PubMed ID: 25586523
[No Abstract] [Full Text] [Related]
58. Plasma prostacyclin levels in Behçet's disease.
Hizli N; Sahin G; Sahin F; Kansu E; Duru S; Karacadag S; Batman F; Dundar S; Zileli T; Telatar H
Lancet; 1985 Jun; 1(8443):1454. PubMed ID: 2861400
[No Abstract] [Full Text] [Related]
59. Activated protein C resistance in Behçet's disease.
Koşar A; Haznedaroğlu IC; Büyükaşik Y; Kirazli S; Dündar SV
Rheumatol Int; 1998; 17(6):249-50. PubMed ID: 9592866
[No Abstract] [Full Text] [Related]
60. Interleukin-15 and its receptor (IL-15Rα) serve as new therapeutic implications for Behçet's disease.
He Y; Huang C; Wu BM; Li J
Rheumatol Int; 2014 Aug; 34(8):1173-4. PubMed ID: 24046145
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
